Disclosure. Dr. Maloney has no commercial relationship with Dental Centre Turkey or any affiliated entity. She did not receive payment, travel, accommodation, equipment, or any other consideration in connection with this piece. The publication’s standing disclosures are at /disclosures/.
What this review is and is not
This review is a desk review. I have not visited Dental Centre Turkey in person. My evidence is the UK Advertising Standards Authority’s upheld ruling against the entity (November 2022), the Companies House public record for Dental Centre Turkey UK Ltd, the Turkish Ministry of Health’s regulations governing Health Tourism Authorization Certificate holders, and the clinical and regulatory literature on the facilitator model in dental tourism. The review does not reach Categories 1 and 2 in the normal sense — clinical decision-making and procedure execution cannot be meaningfully assessed when the treating clinician cannot be identified. Instead, this review documents the structural failure that exists before the patient reaches a treatment chair.
The clinical-standards framework permits registration-and-accountability reviews where the published evidence does not allow clinical assessment. The Greenfield Dental Clinic, Hanoi review is the previous worked example: a clinic whose marketed clinical roster failed before a patient gets to Category 1. Dental Centre Turkey fails at an earlier step: not a clinician who cannot be verified, but a model that structurally prohibits verification by any patient.
The corporate structure: what a patient does not know
Dental Centre Turkey UK Ltd is registered at Companies House (Company Number 09728638). It was incorporated on 12 August 2015. Its registered address is 3 Warren Yard, Wolverton Mill, Milton Keynes MK12 5NW — the premises of an accountancy firm, not an operational dental facility.
The person with significant control is Ms Louise Mary King, a British national, holding 75% or more of shares and voting rights as notified on 6 April 2016. Former directors include Kemal Erkeç (resigned 24 May 2017) and Graham Coombs-Hoar (resigned 27 March 2017). Neither is identified as a dentist in any accessible public record.
This corporate structure is not itself unusual for a health tourism facilitator — a UK company that coordinates bookings on behalf of overseas clinics. What is unusual is the marketing: DCT’s website, Instagram, and Google advertisements presented DCT as the clinical operator, using “we,” “our team,” and patient testimonials framed as referring to the treating clinical team, when no DCT employee is involved in treatment and when DCT does not employ, credential, or oversee the dentists who will actually operate on the patient.
The ASA ruling: what was found and what was ordered
The UK Advertising Standards Authority issued its ruling against Dental Centre Turkey UK Ltd on 16 November 2022 (reference A22-1157178). Three grounds were upheld:
Ground 1 — Misleading registered address. The Milton Keynes address implied to consumers that DCT operated a UK-based head office. It is the address of an accountancy firm. Consumers who identified a UK address as evidence of accountability — a reasonable inference — were misinformed.
Ground 2 — Misrepresentation as clinical operator. Instagram advertisements presented DCT as performing dental procedures and operating dental clinics, when DCT is a referral intermediary. DCT’s role is to facilitate bookings at Turkish clinics; it does not perform clinical work, employ clinical staff, or bear clinical responsibility for treatment outcomes.
Ground 3 — Testimonials and marketing language creating a false impression. The use of “we,” “our team,” and testimonials in the advertising was calculated to create the impression that the clinical staff promoting the service were DCT employees or representatives. They were not.
The ASA’s ruling required that the advertisements could not reappear in their existing form and required DCT to clarify in all future advertising that it does not operate a UK head office and does not perform dental treatment.
The ruling is publicly accessible at the ASA’s own website. It is primary evidence — not a complaint, not an allegation. It is a finding by a statutory body operating under a formal adjudication process, with a right of reply afforded to DCT, which exercised that right and was nonetheless found against on all three grounds.
The clinical relevance is direct. A patient who booked with DCT believing they were booking with the clinical entity whose team had appeared in marketing content did not consent to treatment by an unidentified clinical operator. That gap — between who the patient believes is responsible and who is actually responsible — is a consent problem as well as a commercial problem.
Category 1 — Clinical decision-making
I cannot assess whether DCT’s clinical decision-making is sound for the same reason a patient cannot: there is no named clinician against whom the assessment can be anchored. The category requires evidence of pre-treatment imaging, treatment planning, and documented indication for the recommended procedure. None of these are assessable when the entity that will perform the work cannot be named.
DCT’s website, at the time of this review, did not publish the names of any treating dentists at the Antalya or Fethiye clinics it facilitates. It did not publish the qualifications of any treating dentist. It did not publish the registration numbers of any treating dentist against any regulatory body — including the Turkish Dental Association’s register, the Turkish Ministry of Health’s licensed practitioner records, or any foreign register.
A patient who cannot identify the treating dentist’s name cannot verify their qualifications. A patient who cannot identify the treating clinical entity cannot check whether it holds a valid International Health Tourism Authorization Certificate under the Turkish Ministry of Health’s 2017 regulation. Both of these are preconditions for informed consent that DCT’s model does not meet.
Category 2 — Procedure execution
DCT’s website and social media publish patient result images. These cannot be assessed without knowing who performed the procedures, under what conditions, using what materials, sourced through what supply chain. The Ivoclar Vivadent claim — that DCT has been certified as “the largest provider of e.max restorations in Turkey” — is a supplier volume relationship, not a clinical quality accreditation. Ivoclar Vivadent (now Ivoclar) certifies volume and material compliance; it does not audit clinical decision-making or execution quality. The distinction matters for a patient trying to assess whether the restoration they are about to receive will last.
Category 3 — Sterilisation and infection control
Sterilisation and infection control standards attach to a physical facility and a clinical governance structure. DCT’s facilitator model means that no single clinical entity can be assessed. DCT’s Antalya location description does not identify a specific licensed dental facility, named clinical director, or infection control officer.
Category 4 — Documentation and records
The Turkish Ministry of Health’s International Health Tourism Authorization Certificate system requires that certified providers maintain patient records and make them accessible to the patient on request. Whether the specific Turkish dental clinics DCT facilitates hold this certificate is not publicly verifiable — the Ministry’s Health Tourism Authorization Certificate registry was not accessible during this review. DCT’s public communications do not publish certificate numbers for the facilities it facilitates.
Informed consent in this model is structurally compromised before the patient arrives at the chair: the patient cannot have consented to treatment by a named clinician when no named clinician has been identified.
Category 5 — Post-treatment support and continuity of care
A recurring pattern in patient accounts of DCT, documented in the Euronews October 2022 investigation and in lower-rated reviews cited in that coverage, is difficulty reaching DCT’s UK-based support operation after returning home. DCT, as a facilitator, has no clinical obligation to manage post-treatment complications. The Turkish clinics it facilitates have clinical staff, but those staff are not identified to the patient at the point of booking, and the patient has no named clinical contact to approach when complications arise.
The attorney Burcu Holmgren of London Legal International, interviewed by Euronews in October 2022, noted that legal redress for Turkish dental complications takes approximately two years and is costly — and that clinical complications typically present long before any legal process concludes. The structural position of an international patient with a failed DCT-facilitated procedure is: no named treating clinician, no clinical entity to hold responsible under UK law, a Turkish legal process spanning two years, and an NHS system that will provide emergency stabilisation but is under no obligation to fund remedial restorative work.
The Turkish regulatory backdrop
Turkey has a genuine regulatory framework. Law No. 3224 (1985) established the Turkish Dental Association (TDB) as a mandatory registration body for practising dentists. The Ministry of Health’s International Health Tourism Authorization Certificate system — enacted in 2017 — requires certified clinics to meet quality standards and maintain designated health tourism units. As of 2026, Turkey has approximately 1.4–1.5 million health tourists annually, of whom the Turkish Dental Association estimates 150,000–250,000 visit specifically for dental work.
The framework has two documented structural weaknesses that are directly relevant to DCT’s model.
First, enforcement capacity. A 2022 Euronews investigation found that Berna Aytaç, head of the Istanbul Chamber of Dentists, reported approximately 300 new dental clinics had opened in Antalya alone in the two years preceding that report, against a workforce of approximately 20 provincial Ministry of Health inspectors. The ratio is not consistent with comprehensive oversight.
Second, public registry access. The Ministry of Health maintains a list of International Health Tourism Authorization Certificate holders at its health tourism database. That registry was not publicly accessible during this review (the URL returned a 403 Forbidden response). A patient trying to verify, from outside Turkey, whether a specific clinic holds a valid certificate cannot do so through any public-facing tool I was able to access.
The dental tourism trust gap long read documents why marketplace ratings, certifications, and regulatory bodies each leak at a different point. Turkey’s framework is one of the better-structured frameworks in the dental tourism destination market. It does not close the gap for a patient booking through a facilitator whose model removes the clinical operator’s identity from the booking process.
What I cannot assess and what that means
I have not visited Dental Centre Turkey’s Antalya or Fethiye facilities. I cannot say whether the Turkish clinics DCT facilitates produce good clinical outcomes, employ competent dentists, or operate to international infection-control standards. Those things may be true. I cannot assess them because DCT’s model does not produce the information necessary to assess them.
This is the finding: not that the treatment is certainly bad, but that no patient can establish whether it is good. That is not a finding I can resolve in DCT’s favour. A patient cannot make an informed decision about treatment they cannot verify, performed by a clinician they cannot name, at a facility they cannot check.
The four-filter framework for evaluating overseas dental treatment asks, at Filter 3: can you verify the credential claims the clinic makes? For DCT, the answer is no — and the ASA has now placed that answer in a formal regulatory finding accessible to any patient who looks.
Overall finding
FAIL — not recommended for Australian or international patients.
The finding does not rest on a single clinical failure but on a structural accountability failure that exists before any clinical question is reached. The ASA ruling confirms the misrepresentation. The Companies House record confirms the corporate structure. The absence of named clinicians, published credentials, and verifiable facility certifications is documented. The post-treatment accountability structure is, as a structural matter, not one the patient can rely on.
The when to save a tooth and when to replace it framework, the why most implants do not need bone grafting framework, and the All-on-4 patient guide are the clinical tools a patient uses to evaluate the recommendation they have received. They presuppose that the patient can identify the clinician making the recommendation. In DCT’s model, they cannot. The tools cannot be applied to an anonymous clinical operator.
Re-review cadence: 12 months, or earlier on submission of evidence that DCT has published named treating clinicians, their verified qualifications, their registration numbers against a public registry, and the International Health Tourism Authorization Certificate numbers of the specific facilities it facilitates.